{
  "case_id": "case_0027",
  "provider": "openai",
  "status": "processed",
  "patient_demographics": {
    "age": 35.32,
    "sex": "Male",
    "genderIdentity": "Transgender Male",
    "ancestry": "European"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\nAgree with lesion involving:\n- right optic nerve.",
      "structured_data": {
        "gt_lesions_english": [
          "right optic nerve (cranial nerve II)"
        ],
        "ft_lesions_parsed": [
          {
            "location": "optic nerve",
            "side": "right",
            "qualifier": null
          }
        ],
        "exact_matches": [
          "right optic nerve (cranial nerve II)"
        ],
        "imprecise_matches": [],
        "missing_lesions_from_ft": [],
        "additional_lesions_in_ft": []
      },
      "scoring": {
        "gt_lesion_count": 1,
        "correctly_identified_count": 1,
        "imprecisely_identified_count": 0,
        "missed_lesion_count": 0,
        "additional_lesion_count": 0,
        "proportion_correct": 1.0,
        "proportion_imprecise": 0.0,
        "proportion_missed": 0.0,
        "proportion_additional": 0.0
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included Multiple sclerosis.\n\nAgree to also consider:\n- NMOSD (AQP4+), MOGAD, Neurosarcoid, Neurosyphilis and Compressive Optic Neuropathy.\n\nOther possible differentials:\n- SLE, Bartonella and Retinal Detachment.\n- Also feasible but of low probability: TB, Beh\u00e7et's, Lyme, Lymphoma, Vasculitis, Sjogren's and Leber's Hereditary Optic Neuropathy.\n\nThe following suggested diagnoses have a low probability of providing a unifying explanation for the full clinical presentation:\n- Non-arteritic anterior ischemic optic neuropathy (NAION) (atypical for age, usually > 50)\n- Toxic or nutritional optic neuropathy (e.g., alcohol-related, medication-induced, vitamin B12 deficiency)\n- Retinal vascular occlusion or severe macular disease causing monocular visual loss",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Demyelinating optic neuritis (multiple-sclerosis\u2013associated or idiopathic)",
          "Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis (MOGAD)",
          "Aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (NMOSD) presenting with optic neuritis",
          "Non-arteritic anterior ischemic optic neuropathy (NAION)",
          "Compressive optic neuropathy (e.g., optic nerve sheath meningioma, orbital mass, pituitary or chiasmal lesion)",
          "Sarcoid-related optic neuropathy",
          "Syphilitic optic neuritis or optic neuropathy",
          "Toxic or nutritional optic neuropathy (e.g., alcohol-related, medication-induced, vitamin B12 deficiency)",
          "Retinal vascular occlusion or severe macular disease causing monocular visual loss"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation"
        },
        "correctly_mentioned_original_gt": [
          "Multiple sclerosis"
        ],
        "missing_original_gt": [],
        "matched_lesion_dx_keys": [
          "Compressive_Optic_Neuropathy",
          "Syphilis",
          "AQP4_NMOSD",
          "Neurosarcoidosis",
          "MS",
          "MOGAD"
        ],
        "missing_lesion_dx_keys": [
          "CNS_Tuberculosis",
          "Bartonella_Henselae",
          "Idiopathic_Optic_Neuritis",
          "Behcet_Disease",
          "Infection_Lyme",
          "Retinal_Detachment",
          "CNS_Lymphoma",
          "CNS_Vasculitis",
          "Autoimmune_Myelitis_Sjogren",
          "Autoimmune_Myelitis_SLE",
          "Optic_Neuropathy_Nonspecific",
          "Leber_Hereditary_Optic_Neuropathy"
        ],
        "missing_common_names": [
          "Bartonella",
          "Retinal Detachment",
          "SLE"
        ],
        "missing_low_prob_names": [
          "TB",
          "Beh\u00e7et's",
          "Lyme",
          "Lymphoma",
          "Vasculitis",
          "Sjogren's",
          "Leber's Hereditary Optic Neuropathy"
        ],
        "additional_diagnoses": [
          "Non-arteritic anterior ischemic optic neuropathy (NAION)",
          "Toxic or nutritional optic neuropathy (e.g., alcohol-related, medication-induced, vitamin B12 deficiency)",
          "Retinal vascular occlusion or severe macular disease causing monocular visual loss"
        ]
      },
      "scoring": {
        "primary_diagnosis_included": 1,
        "primary_diagnosis_name": "Multiple sclerosis",
        "gt_total_count": 1,
        "gt_matched_count": 1,
        "gt_missed_count": 0,
        "gt_coverage_percentage": 1.0,
        "additional_less_plausible_count": 3,
        "comorbidity_missing_count": 0,
        "other_considerations_missed_count": 0,
        "lesion_ddx_total_count": 18,
        "lesion_ddx_matched_count": 6,
        "lesion_ddx_missed_common_count": 3,
        "lesion_ddx_missed_low_prob_count": 7,
        "lesion_ddx_coverage_percentage": 0.3333333333333333
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\n\n- Agree with the suggested MRI including the Brain and Orbits and CSF test for Oligoclonal Bands - would potentially inform a diagnosis/details of multiple sclerosis.\n\nTo evaluate other differential diagnoses:\n- Agree with considering: anti-MOG, ANA, CRP, anti-AQP4, ENA, ACE, HIV, ANCA, syphilis, ESR, lyme, CSF (cytology).\n- Could also consider testing: anti-dsDNA, bartonella, TB, CSF (flow cytometry).",
      "structured_data": {
        "gt_required_tests_primary": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "Urgent comprehensive ophthalmologic assessment including dilated fundus examination",
          "MRI of brain, orbits, and cervical spine with gadolinium",
          "Automated visual field testing (e.g., Humphrey perimetry)",
          "Optical coherence tomography of retinal nerve fiber layer",
          "Visual evoked potentials",
          "Colour vision testing (Ishihara plates)",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "C-reactive protein",
          "Erythrocyte sedimentation rate",
          "Blood glucose",
          "HbA1c",
          "Lipid profile",
          "Vitamin B12",
          "Serum folate",
          "Serum angiotensin-converting enzyme level",
          "Antinuclear antibody",
          "Extractable nuclear antigen panel",
          "Antineutrophil cytoplasmic antibodies",
          "Syphilis serology (treponemal antibody and VDRL or RPR)",
          "HIV serology",
          "Aquaporin-4 (AQP4-IgG) antibody",
          "Myelin oligodendrocyte glycoprotein (MOG-IgG) antibody",
          "Lyme disease serology (Borrelia burgdorferi antibodies) if epidemiologically indicated",
          "Chest X-ray",
          "Lumbar puncture with cerebrospinal fluid analysis including cell count, protein, glucose, oligoclonal bands, IgG index, cytology, and infectious studies as indicated",
          "Blood pressure measurement and cardiovascular risk assessment"
        ],
        "all_identified_ft_keys": [
          "Lipid_Profile",
          "MOG_Antibodies",
          "CRP",
          "ENA_Panel",
          "MRI_Orbits",
          "LFT",
          "Vitamin_B12",
          "Serum_ACE",
          "Glucose_HbA1c",
          "CSF_Oligoclonal_Bands",
          "U_and_E",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "Lyme_Serology",
          "CSF_General",
          "FBC",
          "ANA",
          "OCT",
          "MRI_Cervical_Spine",
          "Chest_XRay",
          "Folate",
          "Ophthalmology Assessment",
          "Colour Vision",
          "ANCA",
          "HIV_Test",
          "CSF_Cytology",
          "Serum_Immunoglobulins",
          "VEP",
          "MRI_Brain",
          "ESR",
          "Automated_Visual_Fields"
        ],
        "found_tests_primary": [
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests_primary": [],
        "expected_inv_keys_ddx": [
          "Anti_dsDNA",
          "CSF_Flow_Cytometry",
          "ANA",
          "CRP",
          "MOG_Antibodies",
          "Bartonella_Serology",
          "TB_Screen",
          "ENA_Panel",
          "Serum_ACE",
          "HIV_Test",
          "ANCA",
          "CSF_Cytology",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "ESR",
          "Lyme_Serology"
        ],
        "found_inv_keys_ddx": [
          "MOG_Antibodies",
          "ANA",
          "CRP",
          "AQP4_Antibodies",
          "ENA_Panel",
          "Serum_ACE",
          "HIV_Test",
          "CSF_Cytology",
          "ANCA",
          "Syphilis_Serology",
          "ESR",
          "Lyme_Serology"
        ],
        "missing_inv_keys_ddx": [
          "Anti_dsDNA",
          "CSF_Flow_Cytometry",
          "Bartonella_Serology",
          "TB_Screen"
        ]
      },
      "scoring": {
        "primary_tests_required_count": 3,
        "primary_tests_found_count": 3,
        "primary_tests_missed_count": 0,
        "primary_tests_coverage_percentage": 1.0,
        "ddx_tests_expected_count": 16,
        "ddx_tests_found_count": 12,
        "ddx_tests_coverage_percentage": 0.75
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Not appropriate to start treatment immediately.\n  \nCorrectly identified the following:\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n  \nAdditional factors not mentioned:\n\n- Presenting complaint is not specified, so no indication what the current issue is and whether neurological signs are new or old.\n\nDMTs: Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Safety screen for contraindications like active infection is required before immunosuppression.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "High-dose intravenous methylprednisolone (e.g., 1 g IV daily for 3 days)",
            "timing": "Start Now",
            "reasons": [
              "Severe unilateral visual impairment (6/60) consistent with acute optic neuritis of approximately two weeks' duration",
              "High-dose IV corticosteroids accelerate visual recovery in demyelinating optic neuritis",
              "No clinical evidence of raised intracranial pressure or systemic infection on current assessment"
            ]
          },
          {
            "treatment": "High-dose oral prednisolone taper following IV methylprednisolone",
            "timing": "Delay",
            "reasons": [
              "Commence immediately after completing IV pulses rather than before",
              "Short taper mitigates rebound symptoms while limiting duration of systemic steroid exposure"
            ]
          },
          {
            "treatment": "Proton pump inhibitor for gastric protection during steroid therapy",
            "timing": "Start Now",
            "reasons": [
              "High-dose corticosteroids increase risk of gastrointestinal irritation and ulceration",
              "Patient has vascular comorbidities and may later require antiplatelet agents, further raising GI risk"
            ]
          },
          {
            "treatment": "Counselling on driving, work, and eye protection with early referral to low-vision and occupational therapy services if deficits persist",
            "timing": "Start Now",
            "reasons": [
              "Monocular visual loss can impair driving and occupational safety",
              "Early education and support reduce accident risk and facilitate adaptation"
            ]
          },
          {
            "treatment": "Initiation of multiple sclerosis disease-modifying therapy if MRI and CSF fulfil diagnostic criteria for MS",
            "timing": "Delay",
            "reasons": [
              "Requires confirmation of dissemination in space and time on MRI and/or CSF oligoclonal bands",
              "Choice and timing of agent depend on disease activity, prognostic markers, and patient factors"
            ]
          },
          {
            "treatment": "Initiation of long-term immunosuppressive therapy for neuromyelitis optica spectrum disorder if AQP4-IgG positive",
            "timing": "Delay",
            "reasons": [
              "NMOSD diagnosis must first be established serologically and radiologically",
              "Agents such as rituximab, inebilizumab, or satralizumab require pre-treatment infection screening and vaccination planning"
            ]
          },
          {
            "treatment": "Antiplatelet therapy and intensive vascular risk factor modification if an ischemic optic neuropathy or retinal vascular occlusion is confirmed",
            "timing": "Delay",
            "reasons": [
              "Ischemic aetiology is not established in this relatively young patient",
              "Therapy should be targeted based on ophthalmic, vascular, and systemic investigations"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "High-dose intravenous methylprednisolone (e.g., 1 g IV daily for 3 days)",
            "timing": "Start Now",
            "reasons": [
              "Severe unilateral visual impairment (6/60) consistent with acute optic neuritis of approximately two weeks' duration",
              "High-dose IV corticosteroids accelerate visual recovery in demyelinating optic neuritis",
              "No clinical evidence of raised intracranial pressure or systemic infection on current assessment"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Presenting complaint is not specified, so no indication whether this is related to MS.",
                "Safety screen for contraindications like active infection is required before immunosuppression."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Not appropriate to start treatment immediately.\n  \nCorrectly identified the following:\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n  \nAdditional factors not mentioned:\n\n- Presenting complaint is not specified, so no indication what the current issue is and whether neurological signs are new or old."
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "Initiation of multiple sclerosis disease-modifying therapy if MRI and CSF fulfil diagnostic criteria for MS",
            "timing": "Delay",
            "reasons": [
              "Requires confirmation of dissemination in space and time on MRI and/or CSF oligoclonal bands",
              "Choice and timing of agent depend on disease activity, prognostic markers, and patient factors"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis.",
                "Safety screen for contraindications like active infection is required before immunosuppression."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Safety screen for contraindications like active infection is required before immunosuppression."
        }
      },
      "scoring": {
        "steroids": {
          "decision_category": "inappropriate_commission",
          "is_unsafe": 1,
          "reasons_total": 2,
          "reasons_acknowledged": 1,
          "reasons_missed": 1,
          "reasons_coverage_percentage": 0.5
        },
        "dmt": {
          "decision_category": "appropriate_caution",
          "is_unsafe": 0,
          "reasons_total": 2,
          "reasons_acknowledged": 1,
          "reasons_missed": 1,
          "reasons_coverage_percentage": 0.5
        }
      }
    }
  }
}